A Real-World Case Study Evaluating the Efficacy and Safety of RBS Cryobiopsy

Inclusion criteria

• Inclusion Criteria:
• Patients are eligible for inclusion if they meet all of the following criteria:

• Age ≥18 years and ≤75 years, with no gender restrictions;
• Presence of a peripheral lung lesion on chest CT
• Patients voluntarily agree to undergo bronchoscopy and meet the requirements for the procedure;
• patients are capable of understanding the purpose of the trial, demonstrate good compliance with the examinations and follow-up, voluntarily participate in the clinical trial, and sign an informed consent form.

Exclusion criteria

• Patients who meet any of the following criteria will be excluded from this study:

• Presence of contraindications for bronchoscopy, including: active massive hemoptysis; recent myocardial infarction or unstable angina; severe cardiac or pulmonary dysfunction; severe hypertension and arrhythmias; uncorrectable bleeding tendencies or severe coagulation disorders (such as platelet count <60×10^9/L), uremia; severe pulmonary artery hypertension; severe superior vena cava syndrome; intracranial hypertension; acute cerebrovascular events; aortic dissection or aneurysm; multiple bullae; extreme systemic exhaustion;
• Female patients who are breastfeeding, pregnant, or planning pregnancy;
• Patients with electromagnetic active implantable medical devices;
• Subjects allergic to anesthetics; or with a history of multiple severe allergies, hereditary allergy history;
• Those who have participated in or are currently participating in drug clinical trials within 3 months before screening, or have participated in other medical device clinical trials within 30 days;
• Any other conditions deemed unsuitable for participation in this clinical trial by the investigator.

Exclusion criteria